Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:22
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:21
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:20
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:19
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:18
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:15
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 15:14
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by web@researchtop... on Fri, 05/25/2012 - 14:37
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by mphilemon@resea... on Fri, 05/25/2012 - 14:18
Select Publications
Bachelot T et al. TAMRAD: A GINECO randomized Phase II trial of everolimus in combination with tamoxifen versus tamoxifen alone in patients (pts) with hormone-receptor positive, HER2 negative metastatic breast cancer (MBC) with prior exposure to aromatase inhibitors (AI). San Antonio Breast Cancer Symposium 2010;Abstract S1-6.
Current Controversies, Recent Developments and Emerging Strategies in the Management of Breast Cancer: A Clinical Investigator Think Tank
Submitted by mphilemon@resea... on Fri, 05/25/2012 - 14:06
TARGET AUDIENCE
This activity is intended for medical oncologists and other healthcare providers involved in the treatment of breast cancer.
OVERVIEW OF ACTIVITY
Editor's Note
Submitted by web@researchtop... on Thu, 05/24/2012 - 12:42
Disclosures
Submitted by mphilemon@resea... on Tue, 05/22/2012 - 14:43
Disclosures:
References
Submitted by mphilemon@resea... on Fri, 05/18/2012 - 14:43
References
Submitted by mphilemon@resea... on Fri, 05/18/2012 - 14:34
References
Submitted by mphilemon@resea... on Fri, 05/18/2012 - 14:27